Követés
Richard Simon
Richard Simon
R Simon Consulting, Formerly Chief, Computational & Systems Biology, National Cancer Institute
E-mail megerősítve itt: mail.nih.gov - Kezdőlap
Cím
Hivatkozott rá
Hivatkozott rá
Év
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald, G Wright, WC Chan, JM Connors, E Campo, RI Fisher, ...
New England Journal of Medicine 346 (25), 1937-1947, 2002
48232002
Optimal two-stage designs for phase II clinical trials
R Simon
Controlled clinical trials 10 (1), 1-10, 1989
39811989
Flexible regression models with cubic splines
S Durrleman, R Simon
Statistics in medicine 8 (5), 551-561, 1989
27081989
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
SJ Pocock, R Simon
Biometrics, 103-115, 1975
26261975
Molecular classification of cutaneous malignant melanoma by gene expression profiling
M Bittner, P Meltzer, Y Chen, Y Jiang, E Seftor, M Hendrix, M Radmacher, ...
Nature 406 (6795), 536-540, 2000
25942000
Polychemotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 352 (9132), 930-942, 1998
21761998
Gene-expression profiles in hereditary breast cancer
I Hedenfalk, D Duggan, Y Chen, M Radmacher, M Bittner, R Simon, ...
New England Journal of Medicine 344 (8), 539-548, 2001
21752001
Bias in error estimation when using cross-validation for model selection
S Varma, R Simon
BMC bioinformatics 7, 1-8, 2006
19602006
Comparison of MR/ultrasound fusion–guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer
MM Siddiqui, S Rais-Bahrami, B Turkbey, AK George, J Rothwax, ...
Jama 313 (4), 390-397, 2015
17452015
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
SS Dave, G Wright, B Tan, A Rosenwald, RD Gascoyne, WC Chan, ...
New England Journal of Medicine 351 (21), 2159-2169, 2004
16782004
Prediction error estimation: a comparison of resampling methods
AM Molinaro, R Simon, RM Pfeiffer
Bioinformatics 21 (15), 3301-3307, 2005
15962005
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
A Rosenwald, AA Alizadeh, G Widhopf, R Simon, RE Davis, X Yu, L Yang, ...
Journal of Experimental Medicine 194 (11), 1639-1648, 2001
14622001
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
A Rosenwald, G Wright, K Leroy, X Yu, P Gaulard, RD Gascoyne, ...
Journal of Experimental Medicine 198 (6), 851-862, 2003
13702003
Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification
R Simon, MD Radmacher, K Dobbin, LM McShane
Journal of the National Cancer Institute 95 (1), 14-18, 2003
12232003
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
M Smith, D Arthur, B Camitta, AJ Carroll, W Crist, P Gaynon, R Gelber, ...
Journal of Clinical Oncology 14 (1), 18-24, 1996
12111996
Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines
LV Rubinstein, RH Shoemaker, KD Paull, RM Simon, S Tosini, P Skehan, ...
JNCI: Journal of the National Cancer Institute 82 (13), 1113-1117, 1990
11821990
Use of archived specimens in evaluation of prognostic and predictive biomarkers
RM Simon, S Paik, DF Hayes
Journal of the National Cancer Institute 101 (21), 1446-1452, 2009
11502009
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
A Rosenwald, G Wright, A Wiestner, WC Chan, JM Connors, E Campo, ...
Cancer cell 3 (2), 185-197, 2003
10962003
SYSTEMIC TREATMENT OF EARLY BREAST-CANCER BY HORMONAL, CYTOTOXIC, OR IMMUNE THERAPY-133 RANDOMIZED TRIALS INVOLVING 31000 RECURRENCES AND 24000 DEATHS AMONG 75000 WOMEN. 2.
O Abe, R Abe, K Asaishi, K Enomoto, T Hattori, Y Ino, K Kikuchi, ...
Lancet 339 (8785), 71-85, 1992
10961992
Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
QH Ye, LX Qin, M Forgues, P He, JW Kim, AC Peng, R Simon, Y Li, ...
Nature medicine 9 (4), 416-423, 2003
10932003
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20